$0.000001
At close: Feb 10, 10:16 AM EDT
Comments
Loading...
BG Medicine Analyst Ratings and Price Targets | OTC:BGMD | Benzinga
BG Medicine Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BG Medicine Corp from these most-recent analyst ratings.
Analyst Ratings for BG Medicine
Data brought to you by Benzinga APIs
FAQ
What is the target price for BG Medicine (BGMD) stock?
There is no price target for BG Medicine
What is the most recent analyst rating for BG Medicine (BGMD)?
There is no analyst for BG Medicine
When was the last upgrade for BG Medicine (BGMD)?
There is no last upgrade for BG Medicine
When was the last downgrade for BG Medicine (BGMD)?
There is no last downgrade for BG Medicine.
When is the next analyst rating going to be posted or updated for BG Medicine (BGMD)?
There is no next analyst rating for BG Medicine.
Is the Analyst Rating BG Medicine (BGMD) correct?
There is no next analyst rating for BG Medicine.
Browse analyst ratings and price targets on all stocks.